Glenmark Pharmaceuticals Limited

GLENMARK

Quarterly results

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Jun 20262,435

    Quarter₹ croreYoY
    Jun 20242,330+8.6%
    Sept 20242,636+18.0%
    Dec 20242,251+64.9%
    Mar 20252,009-6.5%
    Jun 20252,395+2.8%
    Sept 20251,539-41.6%
    Dec 20252,360+4.8%
    Mar 20262,147+6.8%
    Jun 20262,435+1.7%
  • ₹ crore

    Jun 2026115

    Quarter₹ crore
    Jun 202456
    Sept 202483
    Dec 2024129
    Mar 202588
    Jun 202569
    Sept 2025286
    Dec 2025109
    Mar 2026308
    Jun 2026115
  • ₹ crore

    Jun 20262,550

    Quarter₹ crore
    Jun 20242,385
    Sept 20242,719
    Dec 20242,380
    Mar 20252,098
    Jun 20252,464
    Sept 20251,824
    Dec 20252,469
    Mar 20262,454
    Jun 20262,550
  • Cost structure
  • ₹ crore

    Jun 2026454

    Quarter₹ crore
    Jun 2024384
    Sept 2024408
    Dec 2024428
    Mar 2025383
    Jun 2025408
    Sept 2025454
    Dec 2025467
    Mar 2026461
    Jun 2026454
  • ₹ crore

    Jun 20261,907

    Quarter₹ crore
    Jun 20241,767
    Sept 20241,924
    Dec 20241,821
    Mar 20251,738
    Jun 20251,740
    Sept 20251,799
    Dec 20251,945
    Mar 20262,193
    Jun 20261,907
  • Exceptional items and tax
  • ₹ crore

    Jun 2026866

    Quarter₹ crore
    Jun 2024618
    Sept 2024795
    Dec 2024559
    Mar 2025181
    Jun 2025401
    Sept 2025-906
    Dec 2025347
    Mar 2026-107
    Jun 2026866
  • ₹ crore

    Jun 2026130

    Quarter₹ crore
    Jun 2024165
    Sept 2024200
    Dec 2024146
    Mar 202533
    Jun 202571
    Sept 2025-167
    Dec 202564
    Mar 2026-33
    Jun 2026130
  • Profit
  • ₹ crore

    Jun 2026736

    Quarter₹ croreYoY
    Jun 2024454+67.0%
    Sept 2024595+96.8%
    Dec 2024414+2127.6%*
    Mar 2025148-96.8%
    Jun 2025330-27.2%
    Sept 2025-739-224.2%
    Dec 2025282-31.8%
    Mar 2026-74-150.0%
    Jun 2026736+122.8%
  • Per share
  • ₹ per share

    Jun 202626.07

    Quarter₹ per share
    Jun 202416.08
    Sept 202421.09
    Dec 202414.66
    Mar 20255.24
    Jun 202511.70
    Sept 2025-26.19
    Dec 202510.00
    Mar 2026-2.62
    Jun 202626.07
₹ croreJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Income
2,3302,6362,2512,0092,3951,5392,3602,1472,435
Revenue YoY+8.6%+18.0%+64.9%-6.5%+2.8%-41.6%+4.8%+6.8%+1.7%
56831298869286109308115
2,3852,7192,3802,0982,4641,8242,4692,4542,550
Cost structure
384408428383408454467461454
1,7671,9241,8211,7381,7401,7991,9452,1931,907
Exceptional items and tax
618795559181401-906347-107866
1652001463371-16764-33130
Profit
454595414148330-739282-74736
Net profit YoY+67.0%+96.8%+2127.6%*-96.8%-27.2%-224.2%-31.8%-150.0%+122.8%
Per share
16.0821.0914.665.2411.70-26.1910.00-2.6226.07

Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.